Ricerfarma

Ricerfarma is an Italian research-driven pharmaceutical company founded in 1996, specializing in the development of innovative products for oral health, wound care, and dermatology. The company is best known for its pioneering use of high-molecular-weight hyaluronic acid in dental applications, marketed under the global flagship brand Gengigel. Ricerfarma focuses on the clinical validation and intellectual property protection of its formulations, which are designed to mimic the natural hyaluronan found in healthy gingival tissue. Their business model relies on international licensing and partnerships, distributing products to over 80 countries worldwide. Beyond oral care, the company provides therapeutic solutions for conditions such as aphthous ulcers and xerostomia, maintaining a strong emphasis on tissue regeneration and inflammatory control.